Cargando…
Docetaxel: promising and novel combinations in ovarian cancer
Despite considerable progress over the past two decades in the management of advanced ovarian cancer, the majority of patients with this type of malignancy still die from their disease, and the search for new and improved first-line and salvage chemotherapy regimens continues. As part of this work,...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750617/ https://www.ncbi.nlm.nih.gov/pubmed/14661044 http://dx.doi.org/10.1038/sj.bjc.6601498 |